Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: 360iResearch | PRODUCT CODE: 1594482

Cover Image

PUBLISHER: 360iResearch | PRODUCT CODE: 1594482

Neurovascular Catheters Market by Type (Access Catheters, Balloon Catheters, Embolization Catheters), Application (Arteriovenous Malformations, Brain Aneurysm, Embolic Stroke), End-use - Global Forecast 2025-2030

PUBLISHED:
PAGES: 196 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF, Excel & 1 Year Online Access (Single User License)
USD 3939
PDF, Excel & 1 Year Online Access (Enterprise User License)
USD 6969

Add to Cart

The Neurovascular Catheters Market was valued at USD 4.37 billion in 2023, expected to reach USD 4.90 billion in 2024, and is projected to grow at a CAGR of 12.01%, to USD 9.68 billion by 2030.

Neurovascular catheters, integral to the treatment of cerebral vascular disorders, encompass devices used in diagnostic and interventional neurovascular procedures such as embolization, thrombectomy, and angioplasty. The increasing prevalence of neurovascular diseases, technological advancements in minimally invasive surgery, and growing healthcare expenditure drive the demand for these devices, necessitating their development to enhance patient outcomes. Primary applications lie in hospitals and specialized neurology clinics, while end-use dynamics are heavily influenced by the rise in geriatric populations susceptible to neurovascular conditions. Current market growth is buoyed by rapid advancements in catheter technology, including flexible, durable, and trackable materials that improve procedural efficacy and safety. The integration of robotics and AI in catheter procedures presents significant growth opportunities, enhancing precision and reducing human error. Companies can capitalize on these opportunities by investing in R&D for smart catheter technologies and expanding their application in emerging markets. However, challenges include stringent regulatory approvals and high costs associated with innovation, which can impede market growth. Another limitation is the limited number of skilled professionals to perform complex neurovascular interventions, which may hinder widespread adoption. Innovation can be targeted towards enhancing catheter flexibility, biocompatibility, and the development of multifunctional catheters that can assist in various neurovascular procedures, reducing the need for multiple medical interventions. Market players should also focus on strengthening distribution networks to ensure broad accessibility. With North America and Europe currently dominating the market due to advanced healthcare infrastructure, tapping into Asia-Pacific regions presents lucrative potential owing to an increasing healthcare budget and growing awareness of neurovascular health, allowing businesses to expand their portfolio. Overall, as the market evolves, staying attuned to technological advancements and patient-centered innovations will be crucial for sustained business growth in this thriving domain.

KEY MARKET STATISTICS
Base Year [2023] USD 4.37 billion
Estimated Year [2024] USD 4.90 billion
Forecast Year [2030] USD 9.68 billion
CAGR (%) 12.01%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Neurovascular Catheters Market

The Neurovascular Catheters Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rapid shift to minimally invasive brain surgeries
    • Supportive government policies concerning health and creating awareness
    • Rising prevalence of neurological conditions
  • Market Restraints
    • Risk of catheter blockage
  • Market Opportunities
    • Technological development in neurovascular catheters
    • Ongoing advances in designs of catheters
  • Market Challenges
    • Limitation in terms of biocompatibility with neurovascular organs

Porter's Five Forces: A Strategic Tool for Navigating the Neurovascular Catheters Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Neurovascular Catheters Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Neurovascular Catheters Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Neurovascular Catheters Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Neurovascular Catheters Market

A detailed market share analysis in the Neurovascular Catheters Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Neurovascular Catheters Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Neurovascular Catheters Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Neurovascular Catheters Market

A strategic analysis of the Neurovascular Catheters Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Neurovascular Catheters Market, highlighting leading vendors and their innovative profiles. These include Acandis GmbH, Access Vascular, Inc., Balt USA LLC, Biomerics LLC, ICU Medical, Inc., Imperative Care Inc., Integra Lifesciences Corporation, Johnson & Johnson Services, Inc., Medtronic Plc, Microvention Inc. by Terumo Corporation, Penumbra, Inc., Shape Memory Medical Inc., Spiegelberg Gmbh & Co. KG, Stryker Corporation, TE Connectivity, Teleflex Incorporated, and Zeus Industrial Products, Inc..

Market Segmentation & Coverage

This research report categorizes the Neurovascular Catheters Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Access Catheters, Balloon Catheters, Embolization Catheters, and Microcatheters.
  • Based on Application, market is studied across Arteriovenous Malformations, Brain Aneurysm, and Embolic Stroke.
  • Based on End-use, market is studied across Ambulatory Surgical Centers, Clinics, Diagnostic Centers, and Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Product Code: MRR-A339DAEF9DC3

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rapid shift to minimally invasive brain surgeries
      • 5.1.1.2. Supportive government policies concerning health and creating awareness
      • 5.1.1.3. Rising prevalence of neurological conditions
    • 5.1.2. Restraints
      • 5.1.2.1. Risk of catheter blockage
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological development in neurovascular catheters
      • 5.1.3.2. Ongoing advances in designs of catheters
    • 5.1.4. Challenges
      • 5.1.4.1. Limitation in terms of biocompatibility with neurovascular organs
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Neurovascular Catheters Market, by Type

  • 6.1. Introduction
  • 6.2. Access Catheters
  • 6.3. Balloon Catheters
  • 6.4. Embolization Catheters
  • 6.5. Microcatheters

7. Neurovascular Catheters Market, by Application

  • 7.1. Introduction
  • 7.2. Arteriovenous Malformations
  • 7.3. Brain Aneurysm
  • 7.4. Embolic Stroke

8. Neurovascular Catheters Market, by End-use

  • 8.1. Introduction
  • 8.2. Ambulatory Surgical Centers
  • 8.3. Clinics
  • 8.4. Diagnostic Centers
  • 8.5. Hospitals

9. Americas Neurovascular Catheters Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Neurovascular Catheters Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Neurovascular Catheters Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Acandis GmbH
  • 2. Access Vascular, Inc.
  • 3. Balt USA LLC
  • 4. Biomerics LLC
  • 5. ICU Medical, Inc.
  • 6. Imperative Care Inc.
  • 7. Integra Lifesciences Corporation
  • 8. Johnson & Johnson Services, Inc.
  • 9. Medtronic Plc
  • 10. Microvention Inc. by Terumo Corporation
  • 11. Penumbra, Inc.
  • 12. Shape Memory Medical Inc.
  • 13. Spiegelberg Gmbh & Co. KG
  • 14. Stryker Corporation
  • 15. TE Connectivity
  • 16. Teleflex Incorporated
  • 17. Zeus Industrial Products, Inc.
Product Code: MRR-A339DAEF9DC3

LIST OF FIGURES

  • FIGURE 1. NEUROVASCULAR CATHETERS MARKET RESEARCH PROCESS
  • FIGURE 2. NEUROVASCULAR CATHETERS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS NEUROVASCULAR CATHETERS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS NEUROVASCULAR CATHETERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES NEUROVASCULAR CATHETERS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES NEUROVASCULAR CATHETERS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC NEUROVASCULAR CATHETERS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC NEUROVASCULAR CATHETERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR CATHETERS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR CATHETERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. NEUROVASCULAR CATHETERS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. NEUROVASCULAR CATHETERS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. NEUROVASCULAR CATHETERS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. NEUROVASCULAR CATHETERS MARKET DYNAMICS
  • TABLE 7. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY ACCESS CATHETERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY BALLOON CATHETERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY EMBOLIZATION CATHETERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY MICROCATHETERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY ARTERIOVENOUS MALFORMATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY BRAIN ANEURYSM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY EMBOLIC STROKE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL NEUROVASCULAR CATHETERS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS NEUROVASCULAR CATHETERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. BRAZIL NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. CANADA NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. CANADA NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 34. MEXICO NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. MEXICO NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. MEXICO NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. UNITED STATES NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 40. UNITED STATES NEUROVASCULAR CATHETERS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. ASIA-PACIFIC NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 44. ASIA-PACIFIC NEUROVASCULAR CATHETERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 45. AUSTRALIA NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. AUSTRALIA NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. AUSTRALIA NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 48. CHINA NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. CHINA NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. CHINA NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 51. INDIA NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. INDIA NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. INDIA NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 54. INDONESIA NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. INDONESIA NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. INDONESIA NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 57. JAPAN NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. JAPAN NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. JAPAN NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 60. MALAYSIA NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. MALAYSIA NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. MALAYSIA NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 63. PHILIPPINES NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. PHILIPPINES NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. PHILIPPINES NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 66. SINGAPORE NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. SINGAPORE NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. SINGAPORE NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 69. SOUTH KOREA NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. SOUTH KOREA NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. SOUTH KOREA NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 72. TAIWAN NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. TAIWAN NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. TAIWAN NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 75. THAILAND NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. THAILAND NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. THAILAND NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 78. VIETNAM NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. VIETNAM NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. VIETNAM NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR CATHETERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 85. DENMARK NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. DENMARK NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. DENMARK NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 88. EGYPT NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. EGYPT NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. EGYPT NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 91. FINLAND NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. FINLAND NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. FINLAND NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 94. FRANCE NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. FRANCE NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. FRANCE NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 97. GERMANY NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. GERMANY NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. GERMANY NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 100. ISRAEL NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. ISRAEL NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. ISRAEL NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 103. ITALY NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. ITALY NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 105. ITALY NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 106. NETHERLANDS NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. NETHERLANDS NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 108. NETHERLANDS NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 109. NIGERIA NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. NIGERIA NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. NIGERIA NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 112. NORWAY NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. NORWAY NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. NORWAY NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 115. POLAND NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. POLAND NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 117. POLAND NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 118. QATAR NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. QATAR NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 120. QATAR NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 121. RUSSIA NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. RUSSIA NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. RUSSIA NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 124. SAUDI ARABIA NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. SAUDI ARABIA NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. SAUDI ARABIA NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH AFRICA NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH AFRICA NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 129. SOUTH AFRICA NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 130. SPAIN NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. SPAIN NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. SPAIN NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 133. SWEDEN NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. SWEDEN NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. SWEDEN NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 136. SWITZERLAND NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. SWITZERLAND NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. SWITZERLAND NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 139. TURKEY NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. TURKEY NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 141. TURKEY NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED ARAB EMIRATES NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED ARAB EMIRATES NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED ARAB EMIRATES NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED KINGDOM NEUROVASCULAR CATHETERS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED KINGDOM NEUROVASCULAR CATHETERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 147. UNITED KINGDOM NEUROVASCULAR CATHETERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 148. NEUROVASCULAR CATHETERS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 149. NEUROVASCULAR CATHETERS MARKET, FPNV POSITIONING MATRIX, 2023
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!